Is Eucrates Biomedical Acquisition Corp. (EUCR) a Buy, Sell, or Hold?
NASDAQ : EUCR
Eucrates Biomedical Acquisition Corp. — Competitors
$10.04 USD
$0 (0.0%)
- Volume
- 12.7K
- Average Volume
- 1.66K
- Market Capitalization
- $42.23M
- P/E Ratio
- 5.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.25
- Year Low
- $9.87
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.03
EUCR vs. The Competition
| Properties | EUCR | ARTEU | BRACU | BYTSW |
|---|---|---|---|---|
| Market Cap | $42.23M | $82.33M | $33.91M | $1.13M |
| Shares Outstanding | $4.21M | $7.34M | $2.83M | $9.38M |
| P/E Ratio | 5.4 | 0 | -50 | |
| EPS | 1.86 | 0 | -0.24 | |
| Day Low | 10.02 | 11.21 | 12 | 0.066 |
| Day High | 10.04 | 11.21 | 12 | 0.13 |
| Year Low | 9.87 | 9.96 | 10.8 | 0.066 |
| Year High | 10.25 | 11.21 | 14 | 0.13 |
| Average Price 50 | 10.105804 | 10.685 | 12 | 0 |
| Average Price 200 | 10.015746 | 10.43576 | 11.7406 | 0 |
| Volume | 12700 | 1 | 151 | 141.02K |
| Average Volume | - | - | - | - |